FDA Clears AI-Based Type 2 Diabetes Clinical Decision Support System
Gap in Diabetes Technology Use Among Black and White Medicare Beneficiaries is Worsening
COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat Cells
During insulin’s first century, treatments and resources for people with diabetes have steadily progressed. So, too, have relationships between the patient and the provider. A recent Endocrine Society-hosted roundtable highlighted this vital connection and how it has evolved through the decades. Leonard Thompson was 14 years old in 1922, and he was dying of type... Thanks to insulin’s discovery a century ago, diabetes is no longer the death sentence it once was. However, providing care can often be complicated for both in- and outpatient treatment regimens. Potential new models of diabetes care could help ease the burden of both the patients and the providers, whether treatment takes place at home,... A century after its discovery, insulin’s price tag in the U.S. remains alarmingly high for many people living with diabetes. While experts in healthcare and industry have worked with legislators to address the problem, much more needs to be done so that this lifesaving therapy is available to all who need it. When Leonard Thompson’s... Smart insulin. Once-a-week insulin. Thermostable insulin. Researchers around the world are working on a variety of insulin innovations, some of which could be available sooner than you think. In a world where everything is becoming smart — phones, speakers, cars, watches, and even doorbells — will it soon be insulin’s turn? The answer is yes,...Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.
